Arbutus Biopharma Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MORGAN STANLEY | 05/15/2025 | 23.79 M | $83.04 M | 5.34% | 12.48% |
WHITEFORT CAPITAL MANAGEMENT, LP | 05/15/2025 | 13.31 M | $46.44 M | 0.50% | 7.17% |
BLACKROCK, INC. | 05/02/2025 | 12.77 M | $44.56 M | -1.32% | 6.69% |
TWO SEAS CAPITAL LP | 05/15/2025 | 9.47 M | $33.04 M | 8.29% | 5.10% |
VANGUARD GROUP INC | 05/09/2025 | 8.95 M | $31.25 M | -0.30% | 4.70% |
STATE STREET CORP | 05/15/2025 | 4.36 M | $15.23 M | -13.19% | 2.29% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 3.54 M | $12.36 M | 1.69% | 1.86% |
WOODLINE PARTNERS LP | 05/15/2025 | 2.66 M | $9.27 M | 173.33% | 1.39% |
FOURSIXTHREE CAPITAL LP | 05/15/2025 | 2.45 M | $8.55 M | 100.00% | 1.32% |
BLACKBARN CAPITAL PARTNERS LP | 05/14/2025 | 2.34 M | $8.17 M | 0.00% | 1.23% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 2.08 M | $7.25 M | 290.31% | 1.09% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.88 M | $6.56 M | 20.86% | 1.01% |
RUBRIC CAPITAL MANAGEMENT LP | 05/14/2025 | 1.68 M | $5.87 M | 0.00% | 0.88% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.58 M | $5.50 M | -4.54% | 0.83% |
05/14/2025 | 1.35 M | $4.71 M | -7.54% | 0.71% | |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 1.34 M | $4.69 M | -0.18% | 0.71% |
NORTHERN TRUST CORP | 05/13/2025 | 1.28 M | $4.48 M | -3.54% | 0.67% |
FOURWORLD CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.23 M | $4.28 M | 0.00% | 0.66% |
HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 1.25 M | $4.35 M | 11.99% | 0.65% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.22 M | $4.27 M | -0.01% | 0.64% |
SABA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 979.52 K | $3.42 M | 10.31% | 0.53% |
BANK OF MONTREAL /CAN/ | 05/13/2025 | 581.08 K | $2.03 M | 27.46% | 0.30% |
JPMORGAN CHASE & CO | 05/12/2025 | 538.63 K | $1.88 M | -39.90% | 0.28% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 510.51 K | $1.78 M | -0.54% | 0.27% |
STEMPOINT CAPITAL LP | 05/15/2025 | 467.88 K | $1.63 M | 100.00% | 0.25% |
ABRDN PLC | 05/13/2025 | 467.38 K | $1.63 M | 100.00% | 0.25% |
QUINN OPPORTUNITY PARTNERS LLC | 05/14/2025 | 464.51 K | $1.62 M | 14.73% | 0.24% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 458.23 K | $1.60 M | 26.83% | 0.24% |
FREESTONE CAPITAL HOLDINGS, LLC | 05/13/2025 | 442.50 K | $1.54 M | 0.00% | 0.23% |
KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 419.34 K | $1.46 M | -0.33% | 0.22% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 402.36 K | $1.40 M | 249.21% | 0.21% |
CITIGROUP INC | 05/12/2025 | 359.90 K | $1.26 M | 139.93% | 0.19% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 348.22 K | $1.22 M | 1.51% | 0.19% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 348.80 K | $1.22 M | -1.30% | 0.18% |
05/12/2025 | 313.31 K | $1.09 M | 100.00% | 0.16% | |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 295.34 K | $1.03 M | -24.34% | 0.15% |
JANE STREET GROUP, LLC | 05/19/2025 | 280.76 K | $979.85 K | 100.00% | 0.15% |
04/28/2025 | 278.44 K | $971.74 K | 0.00% | 0.15% | |
SWISS NATIONAL BANK | 05/12/2025 | 276.30 K | $964.29 K | 0.00% | 0.14% |
05/14/2025 | 275.00 K | $968.00 K | 100.00% | 0.14% | |
CITIGROUP INC | 05/12/2025 | 261.84 K | $913.81 K | 39.48% | 0.14% |
BARCLAYS PLC | 05/15/2025 | 226.17 K | $789.00 K | -24.17% | 0.12% |
RHUMBLINE ADVISERS | 05/29/2025 | 200.76 K | $700.63 K | 6.45% | 0.11% |
CITIGROUP INC | 05/12/2025 | 199.90 K | $697.65 K | 33.27% | 0.10% |
UBS GROUP AG | 05/13/2025 | 192.29 K | $671.10 K | 90.38% | 0.10% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 183.25 K | $639.54 K | -26.11% | 0.10% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 162.28 K | $566.35 K | 0.00% | 0.09% |
CITADEL ADVISORS LLC | 05/15/2025 | 151.41 K | $528.44 K | -45.45% | 0.08% |
DEUTSCHE BANK AG\ | 05/09/2025 | 146.86 K | $512.55 K | -14.50% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 141.40 K | $493.49 K | 26.25% | 0.07% |
Arbutus Biopharma Corporation institutional Ownership - FAQ's
During the previous two years, 193 institutional investors and hedge funds held shares of Arbutus Biopharma Corporation. The most heavily invested institutionals were:
Farther Finance Advisors, LLC: 0
MORGAN STANLEY: 23.79 M
Whitefort Capital Management, LP: 13.31 M
BlackRock, Inc.: 12.77 M
Two Seas Capital LP: 9.47 M
VANGUARD GROUP INC: 8.95 M
58.60% of Arbutus Biopharma Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 124.44 M shares in the last 24 months. This purchase volume represents approximately $394.46 M in transactions.